Business
VERI MEDTECH (VRHI) Announces Director Purchases 11,376 (aggregate) shares of VRHI Stock in Open Market Transactions
VERI MEDTECH (VRHI) Announces Director Purchases 11,376 (aggregate) shares of VRHI Stock in Open Market Transactions.
About this update from Veri Medtech Holdings Inc.
[{"type":"text","content":"VERI MEDTECH\r\n(VRHI) Announces Director Purchases 11,376 (aggregate) shares of VRHI Stock\r\nin Open Market Transactions\r\n \r\nNEW YORK, September\r\n9, 2025 - OTC Markets -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol:\r\n“VRHI”) (\"Veri Medtech\"), healthcare technology platform, announced\r\ntoday that via open market transactions: \r\nDanny Wilson, Director, completed the additional purchase of 200 shares\r\nof VRHI stock at an average price per share of $1.46. With this\r\npurchase, Mr. Wilson beneficially owns: 497.626 shares of VRHI stock, including\r\nan aggregate of 11,376 shares of VRHI stock purchased by Mr. Wilson\r\nvia open market transactions to date. \r\n \r\nQ2 Key\r\nAccomplishments:\r\n\r\n $2.86 Million in Revenue\r\n Initiated Audit Process with PCAOB\r\n Auditor (in preparation for uplisting)\r\n Relaunched www.VeriMedTech.com\r\n Engaged in Discussions for\r\n Accretive Opportunities in Mergers/Acquisitions (Healthcare Technology\r\n Companies)\r\n\r\n \r\nAbout Veri\r\nMedtech (OTC Markets: VRHI):\r\nVeri Medtech is a publicly-traded healthcare technology company that offers\r\nalternative medicine, personalized diagnostics, and wellness medication on\r\ndemand. The company leverages telehealth infrastructure, diagnostic\r\nintelligence, and scalable digital systems to meet the growing demand for\r\naccessible, stigma-free healthcare. Strategically positioned for growth, Veri\r\nMedTech actively explores acquisitions that complement its core capabilities\r\nand enhance patient engagement across emerging sectors of alternative medicine,\r\nlongevity, and wellness science. With a strong integration and operational\r\nefficiency track record, the company drives accelerated revenue through the\r\ncontinuous generation of high-value patient databases and recurring service\r\nmodels. With a commitment to innovation and patient-centric care, Veri MedTech\r\ncontinues to expand its services and reach, aiming to make personalized\r\nhealthcare more accessible and effective for all. For more information, please\r\nvisit: www.VeriMedTech.com\r\nAbout\r\nVeriheal: Veriheal, a\r\nwholly-owned subsidiary of publicly-traded Veri Medtech Holdings - OTC Markets\r\n(“VRHI”) is a healthcare technology company on a mission to help real people\r\nget real medicine. For m...